Photo of Jason J Lukas

Jason J. Lukas, MD, PhD

Languages: English
Accepting New Patients
Professional Statement
Jason Lukas, M.D. is a board-certified medical oncologist and internal medicine physician who treats patients with all types of cancer and has a particular interest in the management of breast, lung and gastrointestinal cancers, as well as leukemia and lymphoma. Dr. Lukas believes cancer is a devastating and life changing event that can drive people into a therapeutic and psychological maze. He takes a holistic approach to help patients through the labyrinth. In addition, Dr. Lukas is a member of the American Society of Clinical Oncology.
Drexel University College of Medicine
Medical School
Keck School of Medicine of the University of Southern California
Medical School
Professional Associations
American Society of Clinical Oncology
Personal Interests
Hiking, Mountain biking, Road biking, travel, medical missions, reading
Board Certifications
  • American Board of Internal Medicine, Medical Oncology
Clinical Interests
  • appendix cancer
  • breast cancer
  • cancer
  • cancer of pancreas
  • cancer pain
  • cancer survivorship
  • gastrointestinal cancer
  • head and neck cancer care
  • stomach cancer
  • tracheal cancer
Lukas J, Groshen S, Saffari B, Wen W, Reles A, Niu N, Felix J, Jones L, Hall FL, Press MF. The p21WAF1/CIP1 Gene Polymorphism and Expression in Carcinomas of the Breast, Ovary and Endometrium. American Journal of Pathology 150: 167-175, 1997.

Tsang J-L, Zhao Y, Lukas J, Yang X, Shah A, Press M, Shibata D. Telomerase Activity in Normal and Neoplastic Breast. Clinical Cancer Research 3: 627-631, 1997.

Karlyn K, Lukas J, De Francisco J, Brahmbhatt D, Friedman M, Neal R, Smillie L, Shriner K. Changing Highly Active Antiretroviral Therapy (HAART) and its Effects on Viral Load (VL) and CD4 Count. International Conference on AIDS Proceedings 12: 365-368, 1998.

Yang XW, Uziely B, Groshen S, Lukas J, Israel V, Russell C, Dunnington G, Formenti S, Muggia F, and Press MF. MDR1 Gene Expression in Primary and Advanced Breast Cancer. Laboratory Investigation 79: 271-280, 1999.

Lukas J, Niu N, Press MF. p53 Mutations and Expression in Breast Carcinoma in Situ. American Journal of Pathology 156: 183-191, 2000.

Schmider A, Gee C, Friedmann W, Lukas J, Press MF, Lichtenegger W, Reles A. p21 (WAF1/Cip1) Protein Expression is Associated with Prolonged Survival but not with p53 Expression in Epithelial Ovarian Carcinoma. Gynecologic Oncology 77: 237-242, 2000.

Lukas J, Gao D-Q, Keshmeshian M, Wen W-H, Tsao-Wei D, Rosenberg S, Press MF. Alternative and Aberrant Messenger RNA Splicing of the mdm2 Oncogene in Invasive Breast Cancer. Cancer Research 61: 3212-3219, 2001.

Blakely WF, Miller AC, Luo L, Lukas J, Hornby ZD, Hamel CJC, Nelson JT, Escalada NE, Prasanna PGS. Nucleic Acid Molecular Biomarkers for Diagnostic Biodosimetry Applications: Use of the Fluorogenic 5'-nuclease Polymerase Chain Reaction Assay. Military Medicine 167: 16-19, 2002.

Knutson KL, Dang Y, Lu H, Lukas JJ, Almand B, Gad E, Azeke E and Disis ML: IL-2 immunotoxin therapy modulates tumor associated regulatory T cells and leads to lasting immune mediated rejection of breast cancers in neu-transgenic mice. Journal of Immunology 177: 84-91, 2006.

Listerman I, Sun J, Gazzaniga FS, Lukas JJ, Blackburn EH: The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis. Cancer Research 73: 2817–2828, 2013.
The Everett Clinic - Providence Regional Cancer Partnership
1717 13th Street Suite 300
Everett, WA 98201
Affiliated Facilities
Providence Regional Medical Center Everett - Colby